The protective effect of resveratrol on dimethylnitrosamine-induced liver fibrosis in rats
Oxidative stress in liver injury is a major pathogenetic factor in progress of liver fibrosis. Resveratrol, a representative antioxidant derived from grapes, has been reported to show widespread pharmacological properties. In this study, we investigated the protective effects of resveratrol on dimet...
Saved in:
| Published in | Archives of pharmacal research Vol. 33; no. 4; pp. 601 - 609 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Heidelberg
Pharmaceutical Society of Korea
01.04.2010
대한약학회 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0253-6269 1976-3786 1976-3786 |
| DOI | 10.1007/s12272-010-0415-y |
Cover
Loading…
| Abstract | Oxidative stress in liver injury is a major pathogenetic factor in progress of liver fibrosis. Resveratrol, a representative antioxidant derived from grapes, has been reported to show widespread pharmacological properties. In this study, we investigated the protective effects of resveratrol on dimethylnitrosamine (DMN)-induced liver fibrosis in rats. Rats were treated with resveratrol daily by oral gavage for seven days after a single intraperitoneal injection of DMN (40 mg/kg). Resveratrol remarkably recovered body and liver weight loss due to DMNinduced liver fibrosis. Liver histology showed that resveratrol alleviated the infiltration of inflammatory cells and fibrosis of liver tissue. Resveratrol decreased the level of malondialdehyde and increased the levels of glutathione peroxidase and superoxide dismutase. Also, resveratrol significantly inhibited the mRNA expression of inflammatory mediators including inducible nitric oxide, tumor necrosis factor-alpha and interleukin-1beta. In addition, resveratrol showed not only reduced mRNA expression of fibrosis-related genes such as transforming growth factor beta 1, collagen type I, and alpha-smooth muscle actin, but also a significant decrease of hydroxyproline in rats with DMN-induced liver fibrosis. Our results suggest that resveratrol could be used to treat liver injury and fibrosis and be useful in preventing the development of liver fibrosis and cirrhosis. |
|---|---|
| AbstractList | Oxidative stress in liver injury is a major pathogenetic factor in progress of liver fibrosis. Resveratrol, a representative antioxidant derived from grapes, has been reported to show widespread pharmacological properties. In this study, we investigated the protective effects of resveratrol on dimethylnitrosamine (DMN)-induced liver fibrosis in rats. Rats were treated with resveratrol daily by oral gavage for seven days after a single intraperitoneal injection of DMN (40 mg/kg). Resveratrol remarkably recovered body and liver weight loss due to DMN-induced liver fibrosis. Liver histology showed that resveratrol alleviated the infiltration of inflammatory cells and fibrosis of liver tissue. Resveratrol decreased the level of malondialdehyde and increased the levels of glutathione peroxidase and superoxide dismutase. Also, resveratrol significantly inhibited the mRNA expression of inflammatory mediators including inducible nitric oxide, tumor necrosis factor-alpha and interleukin-1beta. In addition, resveratrol showed not only reduced mRNA expression of fibrosis-related genes such as transforming growth factor beta 1, collagen type I, and alpha-smooth muscle actin, but also a significant decrease of hydroxyproline in rats with DMN-induced liver fibrosis. Our results suggest that resveratrol could be used to treat liver injury and fibrosis and be useful in preventing the development of liver fibrosis and cirrhosis. Oxidative stress in liver injury is a major pathogenetic factor in progress of liver fibrosis. Resveratrol, a representative antioxidant derived from grapes, has been reported to show widespread pharmacological properties. In this study, we investigated the protective effects of resveratrol on dimethylnitrosamine (DMN)-induced liver fibrosis in rats. Rats were treated with resveratrol daily by oral gavage for seven days after a single intraperitoneal injection of DMN (40 mg/kg). Resveratrol remarkably recovered body and liver weight loss due to DMN-induced liver fibrosis. Liver histology showed that resveratrol alleviated the infiltration of inflammatory cells and fibrosis of liver tissue. Resveratrol decreased the level of malondialdehyde and increased the levels of glutathione peroxidase and superoxide dismutase. Also, resveratrol significantly inhibited the mRNA expression of inflammatory mediators including inducible nitric oxide, tumor necrosis factor-alpha and interleukin-1beta. In addition, resveratrol showed not only reduced mRNA expression of fibrosis-related genes such as transforming growth factor beta 1, collagen type I, and alpha-smooth muscle actin, but also a significant decrease of hydroxyproline in rats with DMN-induced liver fibrosis. Our results suggest that resveratrol could be used to treat liver injury and fibrosis and be useful in preventing the development of liver fibrosis and cirrhosis.Oxidative stress in liver injury is a major pathogenetic factor in progress of liver fibrosis. Resveratrol, a representative antioxidant derived from grapes, has been reported to show widespread pharmacological properties. In this study, we investigated the protective effects of resveratrol on dimethylnitrosamine (DMN)-induced liver fibrosis in rats. Rats were treated with resveratrol daily by oral gavage for seven days after a single intraperitoneal injection of DMN (40 mg/kg). Resveratrol remarkably recovered body and liver weight loss due to DMN-induced liver fibrosis. Liver histology showed that resveratrol alleviated the infiltration of inflammatory cells and fibrosis of liver tissue. Resveratrol decreased the level of malondialdehyde and increased the levels of glutathione peroxidase and superoxide dismutase. Also, resveratrol significantly inhibited the mRNA expression of inflammatory mediators including inducible nitric oxide, tumor necrosis factor-alpha and interleukin-1beta. In addition, resveratrol showed not only reduced mRNA expression of fibrosis-related genes such as transforming growth factor beta 1, collagen type I, and alpha-smooth muscle actin, but also a significant decrease of hydroxyproline in rats with DMN-induced liver fibrosis. Our results suggest that resveratrol could be used to treat liver injury and fibrosis and be useful in preventing the development of liver fibrosis and cirrhosis. Oxidative stress in liver injury is a major pathogenetic factor in progress of liver fibrosis. Resveratrol, a representative antioxidant derived from grapes, has been reported to show widespread pharmacological properties. In this study, we investigated the protective effects of resveratrol on dimethylnitrosamine (DMN)-induced liver fibrosis in rats. Rats were treated with resveratrol daily by oral gavage for seven days after a single intraperitoneal injection of DMN (40 mg/kg). Resveratrol remarkably recovered body and liver weight loss due to DMNinduced liver fibrosis. Liver histology showed that resveratrol alleviated the infiltration of inflammatory cells and fibrosis of liver tissue. Resveratrol decreased the level of malondialdehyde and increased the levels of glutathione peroxidase and superoxide dismutase. Also, resveratrol significantly inhibited the mRNA expression of inflammatory mediators including inducible nitric oxide, tumor necrosis factor-alpha and interleukin-1beta. In addition, resveratrol showed not only reduced mRNA expression of fibrosis-related genes such as transforming growth factor beta 1, collagen type I, and alpha-smooth muscle actin, but also a significant decrease of hydroxyproline in rats with DMN-induced liver fibrosis. Our results suggest that resveratrol could be used to treat liver injury and fibrosis and be useful in preventing the development of liver fibrosis and cirrhosis. KCI Citation Count: 44 Oxidative stress in liver injury is a major pathogenetic factor in progress of liver fibrosis. Resveratrol, a representative antioxidant derived from grapes, has been reported to show widespread pharmacological properties. In this study, we investigated the protective effects of resveratrol on dimethylnitrosamine (DMN)-induced liver fibrosis in rats. Rats were treated with resveratrol daily by oral gavage for seven days after a single intraperitoneal injection of DMN (40 mg/kg). Resveratrol remarkably recovered body and liver weight loss due to DMNinduced liver fibrosis. Liver histology showed that resveratrol alleviated the infiltration of inflammatory cells and fibrosis of liver tissue. Resveratrol decreased the level of malondialdehyde and increased the levels of glutathione peroxidase and superoxide dismutase. Also, resveratrol significantly inhibited the mRNA expression of inflammatory mediators including inducible nitric oxide, tumor necrosis factor-alpha and interleukin-1beta. In addition, resveratrol showed not only reduced mRNA expression of fibrosis-related genes such as transforming growth factor beta 1, collagen type I, and alpha-smooth muscle actin, but also a significant decrease of hydroxyproline in rats with DMN-induced liver fibrosis. Our results suggest that resveratrol could be used to treat liver injury and fibrosis and be useful in preventing the development of liver fibrosis and cirrhosis. |
| Author | Jung, Kyung Hee Lee, Don-Haeng Lee, Hee-Seung Park, In-Suh Suh, Jun-Kyu Hong, Soon-Sun Zheng, Hong-Mei Hong, Sang-Won |
| Author_xml | – sequence: 1 givenname: Sang-Won surname: Hong fullname: Hong, Sang-Won organization: Department of Biomedical Sciences and Clinical Research Center, College of Medicine, Inha University – sequence: 2 givenname: Kyung Hee surname: Jung fullname: Jung, Kyung Hee organization: Department of Biomedical Sciences and Clinical Research Center, College of Medicine, Inha University – sequence: 3 givenname: Hong-Mei surname: Zheng fullname: Zheng, Hong-Mei organization: Department of Biomedical Sciences and Clinical Research Center, College of Medicine, Inha University – sequence: 4 givenname: Hee-Seung surname: Lee fullname: Lee, Hee-Seung organization: Department of Biomedical Sciences and Clinical Research Center, College of Medicine, Inha University – sequence: 5 givenname: Jun-Kyu surname: Suh fullname: Suh, Jun-Kyu organization: Department of Biomedical Sciences and Clinical Research Center, College of Medicine, Inha University – sequence: 6 givenname: In-Suh surname: Park fullname: Park, In-Suh organization: Department of Biomedical Sciences and Clinical Research Center, College of Medicine, Inha University – sequence: 7 givenname: Don-Haeng surname: Lee fullname: Lee, Don-Haeng organization: Department of Biomedical Sciences and Clinical Research Center, College of Medicine, Inha University – sequence: 8 givenname: Soon-Sun surname: Hong fullname: Hong, Soon-Sun email: hongs@inha.ac.kr organization: Department of Biomedical Sciences and Clinical Research Center, College of Medicine, Inha University, College of Medicine, Inha University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20422370$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001438354$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNp9kU1vFSEUhompsbfVH-DGsDMuUD4GmFk2TdUmTUzMdeOGMMyhpZ2BCkyT---lTnXhoisI53mAc94TdBRTBITeMvqRUao_Fca55oQySmjHJDm8QDs2aEWE7tUR2lEuBVFcDcfopJRbSoWSUr5Cx5x2nAtNd-jn_gbwfU4VXA0PgMH7tsPJ4wzlAbKtOc04RTyFBerNYY6hnRS7hAgkxGl1MOG5mRn7MLZKKDhE3LzyGr30di7w5mk9RT8-X-zPv5Krb18uz8-uiBNaVyKnqYNuGC1AP-qJ-U6PCih10nLrrAYq3cRpqwqrOu6Vtj04NjBQ_Th4KU7Rh-3emL25c8EkG_6s18ncZXP2fX9pGBM9lbqx7ze2tfxrhVLNEoqDebYR0lqMFmJg7Vu8ke-eyHVcYDL3OSw2H8zf0TWAbYBrXZcM_h_CqHmMx2zxmBaPeYzHHJqj_3NcqLaGFGu2YX7W5JtZ2ivxGrK5TWuOba7PSL8BWDylqA |
| CitedBy_id | crossref_primary_10_1080_08923973_2019_1688829 crossref_primary_10_1016_j_sjbs_2017_09_003 crossref_primary_10_1371_journal_pone_0030867 crossref_primary_10_3389_fphys_2022_895242 crossref_primary_10_1167_iovs_18_26248 crossref_primary_10_3889_oamjms_2015_038 crossref_primary_10_1016_j_cbi_2014_12_031 crossref_primary_10_3390_ijms25073746 crossref_primary_10_1165_rcmb_2016_0192OC crossref_primary_10_1111_bph_14573 crossref_primary_10_1016_j_cbi_2014_07_007 crossref_primary_10_3892_mmr_2015_4497 crossref_primary_10_1152_ajpgi_00083_2011 crossref_primary_10_1002_gch2_202400181 crossref_primary_10_3390_molecules28237936 crossref_primary_10_1080_10715762_2019_1624742 crossref_primary_10_1111_ijcp_13692 crossref_primary_10_1097_MEG_0000000000002483 crossref_primary_10_4196_kjpp_2023_27_2_143 crossref_primary_10_1016_j_bfopcu_2017_09_005 crossref_primary_10_3390_ijms25179346 crossref_primary_10_1016_j_abb_2017_06_017 crossref_primary_10_1016_j_ijbiomac_2018_08_062 crossref_primary_10_3390_nu13030933 crossref_primary_10_1371_journal_pone_0158657 crossref_primary_10_1016_j_bbadis_2017_09_008 crossref_primary_10_3389_fphar_2015_00303 crossref_primary_10_4196_kjpp_2024_28_4_345 crossref_primary_10_1016_j_foodchem_2012_11_094 crossref_primary_10_1111_jfbc_12594 crossref_primary_10_1177_0748233713498437 crossref_primary_10_1177_1535370216675065 crossref_primary_10_1016_j_fct_2014_04_023 crossref_primary_10_1155_2015_506390 crossref_primary_10_1016_j_jds_2023_06_027 crossref_primary_10_1016_j_ejmech_2012_12_062 crossref_primary_10_5812_hepatmon_103902 crossref_primary_10_1111_j_1471_4159_2011_07236_x crossref_primary_10_1002_ibd_21843 crossref_primary_10_1371_journal_pone_0019881 crossref_primary_10_1093_gerona_glq184 crossref_primary_10_3389_fphar_2025_1530797 crossref_primary_10_5812_hepatmon_12074 crossref_primary_10_1016_j_etap_2012_07_004 crossref_primary_10_2147_JIR_S470318 crossref_primary_10_1039_C4FO00342J crossref_primary_10_1155_2020_7171498 |
| Cites_doi | 10.1016/S0006-2952(03)00403-9 10.1016/S0168-8278(02)00103-4 10.1074/jbc.M212042200 10.1080/08977190500095980 10.1016/0024-3205(94)00763-2 10.1126/science.274.5291.1379 10.1111/j.1600-0676.1998.tb00150.x 10.1111/j.1432-1033.1968.tb00428.x 10.2174/1389200023337171 10.1016/j.bbrc.2003.08.105 10.1002/jat.1260 10.1111/j.1745-7254.2008.00807.x 10.1152/ajpgi.90358.2008 10.1001/jama.246.19.2177 10.1016/S0300-483X(00)00352-8 10.1021/jf0479517 10.1053/he.2000.5848 10.1002/hep.510290307 10.1080/713611034 10.1146/annurev.pharmtox.44.101802.121704 10.1016/S1043-4666(03)00101-7 10.1056/NEJM200011163432007 10.1007/s00011-005-1388-z 10.1186/1471-230X-8-40 10.1002/jat.1249 10.1074/jbc.271.22.12919 10.1002/hep.21047 10.1074/jbc.275.4.2247 10.1016/0003-2697(81)90261-X 10.1016/j.cbi.2006.08.021 10.1046/j.1440-1746.2000.02207.x 10.1007/s10620-007-0112-y 10.1186/1755-1536-1-5 10.1016/j.lfs.2006.11.044 10.1055/s-2001-17554 10.1152/ajplung.00110.2004 10.1084/jem.187.6.917 10.1097/00042737-200107000-00004 10.1074/jbc.M100975200 10.1111/j.1600-0676.1995.tb00098.x 10.1080/10408690390826509 10.1093/jn/134.12.3219 10.1096/fj.04-2691fje 10.1001/jama.1981.03320190035023 10.1016/j.tox.2009.11.008 |
| ContentType | Journal Article |
| Copyright | The Pharmaceutical Society of Korea and Springer Netherlands 2010 |
| Copyright_xml | – notice: The Pharmaceutical Society of Korea and Springer Netherlands 2010 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 ACYCR |
| DOI | 10.1007/s12272-010-0415-y |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Korean Citation Index |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1976-3786 |
| EndPage | 609 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_1138057 20422370 10_1007_s12272_010_0415_y |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -53 -56 -5G -BR -EM -Y2 -~C .86 .UV .VR 06C 06D 0R~ 0VY 1N0 2.D 203 23N 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2WC 2~H 30V 3SX 4.4 406 408 40D 40E 53G 5GY 5VS 67N 67Z 6J9 6NX 8TC 8UJ 95- 95. 95~ 96X 9ZL AAAVM AABHQ AACDK AAHBH AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABDZT ABECU ABFTV ABHQN ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABWNU ABXPI ACAOD ACBXY ACDTI ACGFO ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACREN ACSNA ACUDM ACZOJ ADHHG ADHIR ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFGCZ AFLOW AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BGNMA C1A CAG COF CS3 CSCUP DDRTE DNIVK DPUIP EBLON EBS EIOEI EJD EMOBN ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GRRUI H13 HF~ HG6 HMJXF HRMNR HVGLF HZ~ IJ- IKXTQ IWAJR IXC IXD I~X I~Z J-C J0Z JBSCW JZLTJ KOV KPH KVFHK LLZTM M4Y MA- MZR N2Q N9A NDZJH NF0 NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OVD P19 P2P PF0 PT4 PT5 QOK QOR QOS R89 R9I RHV RNI RNS ROL RPX RSV RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SCLPG SDE SDH SHX SISQX SJN SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SZ9 SZN T13 T16 TEORI TSG TSK TUC U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W48 WK6 WK8 YLTOR Z45 Z7U Z7V Z7W Z83 Z87 Z8O Z8P Z8Q Z91 ZMTXR ZOVNA ZZE ~A9 AAPKM AAYXX ABBRH ABDBE ABFSG ACMFV ACSTC ADHKG AEZWR AFDZB AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION ABRTQ CGR CUY CVF ECM EIF NPM 7X8 AABYN AAFGU AAKSU AAPBV AAYFA ABFGW ABKAS ACBMV ACBRV ACBYP ACIGE ACIPQ ACTTH ACVWB ACWMK ACYCR ADMDM ADOXG AEEQQ AEFTE AESTI AEVTX AFAFS AFNRJ AGGBP AGKHE AIMYW AJDOV AKQUC UNUBA Z7X |
| ID | FETCH-LOGICAL-c377t-5dd4e49baee8b7d1f47b6e00c5a2aca7e05cd20ee83a642f67a8ec191e68b9f53 |
| IEDL.DBID | U2A |
| ISSN | 0253-6269 1976-3786 |
| IngestDate | Tue Nov 21 21:11:44 EST 2023 Thu Sep 04 16:53:21 EDT 2025 Mon Jul 21 06:04:24 EDT 2025 Tue Jul 01 03:46:46 EDT 2025 Thu Apr 24 23:00:08 EDT 2025 Fri Feb 21 02:37:07 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | α-SMA TGF-β Collagen type I Antioxidant enzyme Resveratrol Liver injury |
| Language | English |
| License | http://www.springer.com/tdm |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c377t-5dd4e49baee8b7d1f47b6e00c5a2aca7e05cd20ee83a642f67a8ec191e68b9f53 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 G704-000010.2010.33.4.020 |
| PMID | 20422370 |
| PQID | 733913772 |
| PQPubID | 23479 |
| PageCount | 9 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_1138057 proquest_miscellaneous_733913772 pubmed_primary_20422370 crossref_primary_10_1007_s12272_010_0415_y crossref_citationtrail_10_1007_s12272_010_0415_y springer_journals_10_1007_s12272_010_0415_y |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20100400 2010-4-00 2010-Apr 20100401 2010-04 |
| PublicationDateYYYYMMDD | 2010-04-01 |
| PublicationDate_xml | – month: 4 year: 2010 text: 20100400 |
| PublicationDecade | 2010 |
| PublicationPlace | Heidelberg |
| PublicationPlace_xml | – name: Heidelberg – name: Korea (South) |
| PublicationTitle | Archives of pharmacal research |
| PublicationTitleAbbrev | Arch. Pharm. Res |
| PublicationTitleAlternate | Arch Pharm Res |
| PublicationYear | 2010 |
| Publisher | Pharmaceutical Society of Korea 대한약학회 |
| Publisher_xml | – name: Pharmaceutical Society of Korea – name: 대한약학회 |
| References | Bennett, Kharbanda, Tuma (CR2) 2003; 66 Rushmore, Kong (CR34) 2002; 3 Chen, Zhang (CR11) 2003; 278 Ohara, Nii, Sakiyama, Tsuchiya, Ogawa (CR30) 2008; 53 Weber, Boll, Stampfl (CR42) 2003; 33 Wu, Ho, Shieh, Lu (CR45) 2005; 53 Jaeschke (CR20) 2000; 15 Casini, Ceni, Salzano, Milani, Schuppan, Surrenti (CR9) 1994; 55 Birrell, McCluskie, Wong, Donnelly, Barnes, Belvisil (CR3) 2005; 19 Donnelly, Newton, Kennedy, Fenwick, Leung, Ito, Russell, Barnes (CR13) 2004; 287 Caro, Cederbaum (CR8) 2004; 44 Shang, Chen, Xiao, Sun, Ding, Xiao (CR35) 2008; 29 Chavez, Reyes-Gordillo, Segovia, Shibayama, Tsutsumi, Vergara, Moreno, Muriel (CR10) 2008; 28 Leonard, Xia, Jiang, Stinefelt, Klandorf, Harris, Shi (CR23) 2003; 309 Niehaus, Samuelsson (CR27) 1968; 6 Tilg, Diehl (CR40) 2000; 343 George, Rao, Stern, Chandrakasan (CR16) 2001; 156 Godichaud, Krisa, Couronne, Dubuisson, Merillon, Desmouliere, Rosenbaum (CR17) 2000; 31 Kim, Rhim, Choi, Kim (CR22) 2001; 276 Malinski, Zera, Angleson, Wensel (CR26) 1996; 271 Nordmann (CR28) 1994; 29 Ramadori, Armbrust (CR32) 2001; 13 Rivera, Shibayama, Tsutsumi, Perez-Alvarez, Muriel (CR33) 2008; 28 Seifert, Bosma, Hendriks, Van Leeuwen, Van Thiel-de Ruiter, Seifert-Bock, Knook, Brouwer (CR36) 1995; 15 CR4 Wills, Suresh, Arun, Asha (CR43) 2006; 164 Bujanda, Hijona, Larzabal, Beraza, Aldazabal, Garcia-Urkia, Sarasqueta, Cosme, Irastorza, Gonzalez, Arenas (CR6) 2008; 8 Wolter, Ulrich, Stein (CR44) 2004; 134 Breitkopf, Sawitza, Gressner (CR5) 2005; 23 Ezquerro, Lasarte, Dotor, Castilla-Cortazar, Bustos, Penuelas, Blanco, Rodriguez, Lechuga Mdel, Greenwel, Rojkind, Prieto, Borras-Cuesta (CR14) 2003; 22 Lopez-Velez, Martinez-Martinez, Del Valle-Ribes (CR24) 2003; 43 Ajmo, Liang, Rogers, Pennock, You (CR1) 2008; 295 Novo, Parola (CR29) 2008; 1 Kasdallah-Grissa, Mornagui, Aouani, Hammami, El May, Gharbi, Kamoun, El-Fazaa (CR21) 2007; 80 Friedman (CR15) 2000; 275 Shiba, Shimizu, Yasuda, Ii, Ito (CR38) 1998; 18 Cai, Fang, Ma, Yang, Liu (CR7) 2003; 1637 Cressman, Greenbaum, DeAngelis, Ciliberto, Furth, Poli, Taub (CR12) 1996; 274 Ma, Ma, Wang, Sha, Wu, Zhang (CR25) 2005; 54 Yasuda, Shimizu, Shiba, Ito (CR46) 1999; 29 Shafritz, Oertel, Menthena, Nierhoff, Dabeva (CR37) 2006; 43 Sohara, Znoyko, Levy, Trojanowska, Reuben (CR39) 2002; 37 Wallace, Levy (CR41) 1981; 246 Jamall, Finelli, Que Hee (CR19) 1981; 112 Hierholzer, Harbrecht, Menezes, Kane, Macmicking, Nathan, Peitzman, Billiar, Twardy (CR18) 1998; 187 Pinzani, Marra (CR31) 2001; 21 E. Chavez (415_CR10) 2008; 28 J. A. Malinski (415_CR26) 1996; 271 F. Wolter (415_CR44) 2004; 134 N. Sohara (415_CR39) 2002; 37 415_CR4 W. F. Seifert (415_CR36) 1995; 15 L. C. Wu (415_CR45) 2005; 53 W. G. Niehaus Jr. (415_CR27) 1968; 6 M. A. Birrell (415_CR3) 2005; 19 J. George (415_CR16) 2001; 156 E. Novo (415_CR29) 2008; 1 I. J. Ezquerro (415_CR14) 2003; 22 M. Lopez-Velez (415_CR24) 2003; 43 K. Breitkopf (415_CR5) 2005; 23 A. Kasdallah-Grissa (415_CR21) 2007; 80 P. J. Wills (415_CR43) 2006; 164 A. A. Caro (415_CR8) 2004; 44 T. H. Rushmore (415_CR34) 2002; 3 H. Jaeschke (415_CR20) 2000; 15 L. W. Weber (415_CR42) 2003; 33 S. S. Leonard (415_CR23) 2003; 309 D. A. Shafritz (415_CR37) 2006; 43 Y. J. Cai (415_CR7) 2003; 1637 G. Ramadori (415_CR32) 2001; 13 J. M. Ajmo (415_CR1) 2008; 295 S. L. Friedman (415_CR15) 2000; 275 F. Ohara (415_CR30) 2008; 53 I. S. Jamall (415_CR19) 1981; 112 Z. H. Ma (415_CR25) 2005; 54 R. Nordmann (415_CR28) 1994; 29 J. D. Wallace (415_CR41) 1981; 246 R. G. Bennett (415_CR2) 2003; 66 H. Tilg (415_CR40) 2000; 343 S. Godichaud (415_CR17) 2000; 31 H. Rivera (415_CR33) 2008; 28 L. Bujanda (415_CR6) 2008; 8 A. Casini (415_CR9) 1994; 55 D. E. Cressman (415_CR12) 1996; 274 M. Pinzani (415_CR31) 2001; 21 M. Shiba (415_CR38) 1998; 18 K. Y. Kim (415_CR22) 2001; 276 L. E. Donnelly (415_CR13) 2004; 287 C. Hierholzer (415_CR18) 1998; 187 M. Yasuda (415_CR46) 1999; 29 J. Shang (415_CR35) 2008; 29 A. Chen (415_CR11) 2003; 278 |
| References_xml | – volume: 66 start-page: 867 year: 2003 end-page: 874 ident: CR2 article-title: Inhibition of markers of hepatic stellate cell activation by the hormone relaxin publication-title: Biochem. Pharmacol. doi: 10.1016/S0006-2952(03)00403-9 – volume: 37 start-page: 214 year: 2002 end-page: 221 ident: CR39 article-title: Reversal of activation of human myofibroblast-like cells by culture on a basement membrane-like substrate publication-title: J. Hepatol. doi: 10.1016/S0168-8278(02)00103-4 – volume: 278 start-page: 23381 year: 2003 end-page: 23389 ident: CR11 article-title: The antioxidant (-)-epigallocatechin-3-gallate inhibits rat hepatic stellate cell proliferation in vitro by blocking the tyrosine phosphorylation and reducing the gene expression of platelet-derived growth factorbeta receptor publication-title: J. Biol. Chem. doi: 10.1074/jbc.M212042200 – ident: CR4 – volume: 23 start-page: 77 year: 2005 end-page: 85 ident: CR5 article-title: Characterization of intracellular pathways leading to coinduction of thrombospondin-1 and TGF-beta1 expression in rat hepatic stellate cells publication-title: Growth Factors doi: 10.1080/08977190500095980 – volume: 55 start-page: 1311 year: 1994 end-page: 1316 ident: CR9 article-title: Acetaldehyde regulates the gene expression of matrix-metalloproteinase-1 and -2 in human fat-storing cells publication-title: Life Sci. doi: 10.1016/0024-3205(94)00763-2 – volume: 274 start-page: 1379 year: 1996 end-page: 1383 ident: CR12 article-title: Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice publication-title: Science doi: 10.1126/science.274.5291.1379 – volume: 18 start-page: 196 year: 1998 end-page: 204 ident: CR38 article-title: Expression of type I and type III collagens during the course of dimethylnitrosamine-induced hepatic fibrosis in rats publication-title: Liver doi: 10.1111/j.1600-0676.1998.tb00150.x – volume: 6 start-page: 126 year: 1968 end-page: 130 ident: CR27 article-title: Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation publication-title: Eur. J. Biochem. doi: 10.1111/j.1432-1033.1968.tb00428.x – volume: 3 start-page: 481 year: 2002 end-page: 490 ident: CR34 article-title: Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes publication-title: Curr. Drug Metab. doi: 10.2174/1389200023337171 – volume: 309 start-page: 1017 year: 2003 end-page: 1026 ident: CR23 article-title: Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2003.08.105 – volume: 28 start-page: 147 year: 2008 end-page: 155 ident: CR33 article-title: Resveratrol and trimethylated resveratrol protect from acute liver damage induced by CCl4 in the rat publication-title: J. Appl. Toxicol. doi: 10.1002/jat.1260 – volume: 15 start-page: 1 year: 1995 end-page: 8 ident: CR36 article-title: Beta-carotene (provitamin A) decreases the severity of CCl4-induced hepatic inflammation and fibrosis in rats publication-title: Liver – volume: 29 start-page: 698 year: 2008 end-page: 706 ident: CR35 article-title: Resveratrol improves non-alcoholic fatty liver disease by activating AMP activated protein kinase publication-title: Acta Pharmacol. Sin. doi: 10.1111/j.1745-7254.2008.00807.x – volume: 295 start-page: 833 year: 2008 end-page: 842 ident: CR1 article-title: Resveratrol alleviates alcoholic fatty liver in mice publication-title: Am. J. Physiol. Gastrointest. Liver Physiol. doi: 10.1152/ajpgi.90358.2008 – volume: 246 start-page: 2177 year: 1981 end-page: 2180 ident: CR41 article-title: Blood pressure after stroke publication-title: JAMA doi: 10.1001/jama.246.19.2177 – volume: 156 start-page: 129 year: 2001 end-page: 138 ident: CR16 article-title: Dimethylnitrosamine-induced liver injury in rats: the early deposition of collagen publication-title: Toxicology doi: 10.1016/S0300-483X(00)00352-8 – volume: 53 start-page: 4207 year: 2005 end-page: 4212 ident: CR45 article-title: Antioxidant and antiproliferative activities of Spirulina and Chlorella water extracts publication-title: J. Agric. Food Chem. doi: 10.1021/jf0479517 – volume: 19 start-page: 840 year: 2005 end-page: 841 ident: CR3 article-title: Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NFkappa B-independent mechanism publication-title: FASEB J. – volume: 31 start-page: 922 year: 2000 end-page: 931 ident: CR17 article-title: Deactivation of cultured human liver myofibroblasts by trans-resveratrol, a grapevine-derived polyphenol publication-title: Hepatology doi: 10.1053/he.2000.5848 – volume: 29 start-page: 719 year: 1999 end-page: 727 ident: CR46 article-title: Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats publication-title: Hepatology doi: 10.1002/hep.510290307 – volume: 33 start-page: 105 year: 2003 end-page: 136 ident: CR42 article-title: Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model publication-title: Crit. Rev. Toxicol. doi: 10.1080/713611034 – volume: 134 start-page: 3219 year: 2004 end-page: 3222 ident: CR44 article-title: Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in colorectal cancer: key role of polyamines? publication-title: J. Nutr. – volume: 44 start-page: 27 year: 2004 end-page: 42 ident: CR8 article-title: Oxidative stress, toxicology, and pharmacology of CYP2E1 publication-title: Annu. Rev. Pharmacol. Toxicol. doi: 10.1146/annurev.pharmtox.44.101802.121704 – volume: 22 start-page: 12 year: 2003 end-page: 20 ident: CR14 article-title: A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury publication-title: Cytokine doi: 10.1016/S1043-4666(03)00101-7 – volume: 343 start-page: 1467 year: 2000 end-page: 1476 ident: CR40 article-title: Cytokines in alcoholic and nonalcoholic steatohepatitis publication-title: N. Engl. J. Med. doi: 10.1056/NEJM200011163432007 – volume: 54 start-page: 522 year: 2005 end-page: 527 ident: CR25 article-title: Effect of resveratrol on peritoneal macrophages in rats with severe acute pancreatitis publication-title: Inflamm. Res. doi: 10.1007/s00011-005-1388-z – volume: 29 start-page: 513 year: 1994 end-page: 522 ident: CR28 article-title: Alcohol and antioxidant systems publication-title: Alcohol Alcohol. – volume: 43 start-page: 233 year: 2003 end-page: 244 ident: CR24 article-title: The study of phenolic compounds as natural antioxidants in wine publication-title: Crit. Rev. Food Sci. Nutr. – volume: 8 start-page: 35 year: 2008 ident: CR6 article-title: Resveratrol inhibits nonalcoholic fatty liver disease in rats publication-title: BMC Gastroenterol. doi: 10.1186/1471-230X-8-40 – volume: 1637 start-page: 313 year: 2003 end-page: 318 ident: CR7 article-title: Inhibition of free radical-induced peroxidation of rat liver microsomes by resveratrol and its analogues publication-title: Biochim. Biophys. Acta – volume: 28 start-page: 35 year: 2008 end-page: 43 ident: CR10 article-title: Resveratrol prevents fibrosis, NF-kappa B activation and TGF-beta increases induced by chronic CCl4 treatment in rats publication-title: J. Appl. Toxicol. doi: 10.1002/jat.1249 – volume: 271 start-page: 12919 year: 1996 end-page: 12924 ident: CR26 article-title: High affinity interactions of GTPgammaS with the heterotrimeric G protein, transducin. Evidence at high and low protein concentrations publication-title: J. Biol. Chem. doi: 10.1074/jbc.271.22.12919 – volume: 43 start-page: S89 year: 2006 end-page: S98 ident: CR37 article-title: Liver stem cells and prospects for liver reconstitution by transplanted cells publication-title: Hepatology doi: 10.1002/hep.21047 – volume: 275 start-page: 2247 year: 2000 end-page: 2250 ident: CR15 article-title: Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury publication-title: J. Biol. Chem. doi: 10.1074/jbc.275.4.2247 – volume: 112 start-page: 70 year: 1981 end-page: 75 ident: CR19 article-title: A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues publication-title: Anal. Biochem. doi: 10.1016/0003-2697(81)90261-X – volume: 164 start-page: 25 year: 2006 end-page: 38 ident: CR43 article-title: Antiangiogenic effect of Lygodium flexuosum against Nnitrosodiethylamine-induced hepatotoxicity in rats publication-title: Chem. Biol. Interact. doi: 10.1016/j.cbi.2006.08.021 – volume: 15 start-page: 718 year: 2000 end-page: 724 ident: CR20 article-title: Reactive oxygen and mechanisms of inflammatory liver injury. publication-title: J. Gastroenterol. Hepatol. doi: 10.1046/j.1440-1746.2000.02207.x – volume: 53 start-page: 2222 year: 2008 end-page: 2232 ident: CR30 article-title: Pathophysiological characteristics of dimethylnitrosamine-induced liver fibrosis in acute and chronic injury models: a possible contribution of KLF5 to fibrogenic responses publication-title: Dig. Dis. Sci. doi: 10.1007/s10620-007-0112-y – volume: 1 start-page: 5 year: 2008 ident: CR29 article-title: Redox mechanisms in hepatic chronic wound healing and fibrogenesis publication-title: Fibrogenesis Tissue Repair doi: 10.1186/1755-1536-1-5 – volume: 80 start-page: 1033 year: 2007 end-page: 1039 ident: CR21 article-title: Resveratrol, a red wine polyphenol, attenuates ethanolinduced oxidative stress in rat liver publication-title: Life Sci. doi: 10.1016/j.lfs.2006.11.044 – volume: 21 start-page: 397 year: 2001 end-page: 416 ident: CR31 article-title: Cytokine receptors and signaling in hepatic stellate cells publication-title: Semin. Liver Dis. doi: 10.1055/s-2001-17554 – volume: 287 start-page: L774 year: 2004 end-page: L783 ident: CR13 article-title: Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms publication-title: Am. J. Physiol. Lung Cell Mol. Physiol. doi: 10.1152/ajplung.00110.2004 – volume: 187 start-page: 917 year: 1998 end-page: 928 ident: CR18 article-title: Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock publication-title: J. Exp. Med. doi: 10.1084/jem.187.6.917 – volume: 13 start-page: 777 year: 2001 end-page: 784 ident: CR32 article-title: Cytokines in the liver publication-title: Eur. J. Gastroenterol. Hepatol. doi: 10.1097/00042737-200107000-00004 – volume: 276 start-page: 40591 year: 2001 end-page: 40598 ident: CR22 article-title: N-acetylcysteine induces cell cycle arrest in hepatic stellate cells through its reducing activity publication-title: J. Biol. Chem. doi: 10.1074/jbc.M100975200 – volume: 187 start-page: 917 year: 1998 ident: 415_CR18 publication-title: J. Exp. Med. doi: 10.1084/jem.187.6.917 – volume: 29 start-page: 719 year: 1999 ident: 415_CR46 publication-title: Hepatology doi: 10.1002/hep.510290307 – volume: 23 start-page: 77 year: 2005 ident: 415_CR5 publication-title: Growth Factors doi: 10.1080/08977190500095980 – volume: 1637 start-page: 313 year: 2003 ident: 415_CR7 publication-title: Biochim. Biophys. Acta – volume: 276 start-page: 40591 year: 2001 ident: 415_CR22 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M100975200 – volume: 33 start-page: 105 year: 2003 ident: 415_CR42 publication-title: Crit. Rev. Toxicol. doi: 10.1080/713611034 – volume: 44 start-page: 27 year: 2004 ident: 415_CR8 publication-title: Annu. Rev. Pharmacol. Toxicol. doi: 10.1146/annurev.pharmtox.44.101802.121704 – volume: 156 start-page: 129 year: 2001 ident: 415_CR16 publication-title: Toxicology doi: 10.1016/S0300-483X(00)00352-8 – volume: 271 start-page: 12919 year: 1996 ident: 415_CR26 publication-title: J. Biol. Chem. doi: 10.1074/jbc.271.22.12919 – volume: 275 start-page: 2247 year: 2000 ident: 415_CR15 publication-title: J. Biol. Chem. doi: 10.1074/jbc.275.4.2247 – volume: 309 start-page: 1017 year: 2003 ident: 415_CR23 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2003.08.105 – volume: 66 start-page: 867 year: 2003 ident: 415_CR2 publication-title: Biochem. Pharmacol. doi: 10.1016/S0006-2952(03)00403-9 – volume: 287 start-page: L774 year: 2004 ident: 415_CR13 publication-title: Am. J. Physiol. Lung Cell Mol. Physiol. doi: 10.1152/ajplung.00110.2004 – volume: 53 start-page: 2222 year: 2008 ident: 415_CR30 publication-title: Dig. Dis. Sci. doi: 10.1007/s10620-007-0112-y – volume: 295 start-page: 833 year: 2008 ident: 415_CR1 publication-title: Am. J. Physiol. Gastrointest. Liver Physiol. doi: 10.1152/ajpgi.90358.2008 – volume: 15 start-page: 1 year: 1995 ident: 415_CR36 publication-title: Liver doi: 10.1111/j.1600-0676.1995.tb00098.x – volume: 80 start-page: 1033 year: 2007 ident: 415_CR21 publication-title: Life Sci. doi: 10.1016/j.lfs.2006.11.044 – volume: 55 start-page: 1311 year: 1994 ident: 415_CR9 publication-title: Life Sci. doi: 10.1016/0024-3205(94)00763-2 – volume: 15 start-page: 718 year: 2000 ident: 415_CR20 publication-title: J. Gastroenterol. Hepatol. doi: 10.1046/j.1440-1746.2000.02207.x – volume: 21 start-page: 397 year: 2001 ident: 415_CR31 publication-title: Semin. Liver Dis. doi: 10.1055/s-2001-17554 – volume: 3 start-page: 481 year: 2002 ident: 415_CR34 publication-title: Curr. Drug Metab. doi: 10.2174/1389200023337171 – volume: 1 start-page: 5 year: 2008 ident: 415_CR29 publication-title: Fibrogenesis Tissue Repair doi: 10.1186/1755-1536-1-5 – volume: 37 start-page: 214 year: 2002 ident: 415_CR39 publication-title: J. Hepatol. doi: 10.1016/S0168-8278(02)00103-4 – volume: 22 start-page: 12 year: 2003 ident: 415_CR14 publication-title: Cytokine doi: 10.1016/S1043-4666(03)00101-7 – volume: 6 start-page: 126 year: 1968 ident: 415_CR27 publication-title: Eur. J. Biochem. doi: 10.1111/j.1432-1033.1968.tb00428.x – volume: 43 start-page: S89 year: 2006 ident: 415_CR37 publication-title: Hepatology doi: 10.1002/hep.21047 – volume: 43 start-page: 233 year: 2003 ident: 415_CR24 publication-title: Crit. Rev. Food Sci. Nutr. doi: 10.1080/10408690390826509 – volume: 134 start-page: 3219 year: 2004 ident: 415_CR44 publication-title: J. Nutr. doi: 10.1093/jn/134.12.3219 – volume: 164 start-page: 25 year: 2006 ident: 415_CR43 publication-title: Chem. Biol. Interact. doi: 10.1016/j.cbi.2006.08.021 – volume: 8 start-page: 35 year: 2008 ident: 415_CR6 publication-title: BMC Gastroenterol. doi: 10.1186/1471-230X-8-40 – volume: 18 start-page: 196 year: 1998 ident: 415_CR38 publication-title: Liver doi: 10.1111/j.1600-0676.1998.tb00150.x – volume: 28 start-page: 35 year: 2008 ident: 415_CR10 publication-title: J. Appl. Toxicol. doi: 10.1002/jat.1249 – volume: 278 start-page: 23381 year: 2003 ident: 415_CR11 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M212042200 – volume: 112 start-page: 70 year: 1981 ident: 415_CR19 publication-title: Anal. Biochem. doi: 10.1016/0003-2697(81)90261-X – volume: 274 start-page: 1379 year: 1996 ident: 415_CR12 publication-title: Science doi: 10.1126/science.274.5291.1379 – volume: 28 start-page: 147 year: 2008 ident: 415_CR33 publication-title: J. Appl. Toxicol. doi: 10.1002/jat.1260 – volume: 13 start-page: 777 year: 2001 ident: 415_CR32 publication-title: Eur. J. Gastroenterol. Hepatol. doi: 10.1097/00042737-200107000-00004 – volume: 29 start-page: 698 year: 2008 ident: 415_CR35 publication-title: Acta Pharmacol. Sin. doi: 10.1111/j.1745-7254.2008.00807.x – volume: 54 start-page: 522 year: 2005 ident: 415_CR25 publication-title: Inflamm. Res. doi: 10.1007/s00011-005-1388-z – volume: 19 start-page: 840 year: 2005 ident: 415_CR3 publication-title: FASEB J. doi: 10.1096/fj.04-2691fje – volume: 31 start-page: 922 year: 2000 ident: 415_CR17 publication-title: Hepatology doi: 10.1053/he.2000.5848 – volume: 53 start-page: 4207 year: 2005 ident: 415_CR45 publication-title: J. Agric. Food Chem. doi: 10.1021/jf0479517 – volume: 246 start-page: 2177 year: 1981 ident: 415_CR41 publication-title: JAMA doi: 10.1001/jama.1981.03320190035023 – ident: 415_CR4 doi: 10.1016/j.tox.2009.11.008 – volume: 343 start-page: 1467 year: 2000 ident: 415_CR40 publication-title: N. Engl. J. Med. doi: 10.1056/NEJM200011163432007 – volume: 29 start-page: 513 year: 1994 ident: 415_CR28 publication-title: Alcohol Alcohol. |
| SSID | ssj0036555 |
| Score | 2.1486576 |
| Snippet | Oxidative stress in liver injury is a major pathogenetic factor in progress of liver fibrosis. Resveratrol, a representative antioxidant derived from grapes,... |
| SourceID | nrf proquest pubmed crossref springer |
| SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 601 |
| SubjectTerms | Animals Antioxidants - administration & dosage Antioxidants - metabolism Antioxidants - therapeutic use Biomarkers - blood Biomarkers - metabolism Body Weight - drug effects Dimethylnitrosamine Lipid Peroxidation - drug effects Liver - drug effects Liver - enzymology Liver - immunology Liver - metabolism Liver - pathology Liver Cirrhosis, Experimental - chemically induced Liver Cirrhosis, Experimental - immunology Liver Cirrhosis, Experimental - metabolism Liver Cirrhosis, Experimental - pathology Liver Cirrhosis, Experimental - prevention & control Male Medicine Organ Size - drug effects Pharmacology/Toxicology Pharmacy Rats Rats, Sprague-Dawley Stilbenes - administration & dosage Stilbenes - therapeutic use 약학 |
| Title | The protective effect of resveratrol on dimethylnitrosamine-induced liver fibrosis in rats |
| URI | https://link.springer.com/article/10.1007/s12272-010-0415-y https://www.ncbi.nlm.nih.gov/pubmed/20422370 https://www.proquest.com/docview/733913772 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001438354 |
| Volume | 33 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Archives of Pharmacal Research, 2010, 33(4), , pp.601-609 |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB7RVkJcEJRXClQWQj1ALSVxHHuPW9SlgKh66EqFi-U4drXqkqDNtlL-PTN5dIUoSOTig-3YyufHTObzZ4C3ibK6iEPCC-0Cxx1KcJ34kovUBVmGjEI3xLY4zU_m2ecLeTGc425GtvsYkuxW6s1htzRVRCMgOmIiebsFOxJdd-LxzdPpuPyKXHZXnWKG4GitT8ZQ5l2v-G0z2qpW4S47848Yabf1zB7Bw8FmZNMe5Mdwz1e7cP_rEBXfhYOzXn-6PWTnm-NUzSE7YGcbZer2CXzHbDYoM-Aqx3oyB6sDQ6f7huSVV_WS1RUrF3SzdLvE-Y4dtz-wGY7OOw6Dki2JycECutl1s2jYomJYr3kK89nx-YcTPlyuwJ1Qas1lWWY-mxTWe12oMgmZKnIfx07a1DqrfCxdmcaYKyz6KCFHUL1D787nupgEKZ7BdlVX_gWwwtFvES2xts9KnWmLj_OZ66wnrSOIx69s3KA8ThdgLM1GM5mAMQiMIWBMG8G72yo_e9mNfxV-g9CZK7cwJJZN6WVtrlYGXYJP6OIIjUZpBGxE1uAMorCIrXx93RglxIR0F9MInveI3zaZkkKaUHEE78chYIY53vy9P3v_VfolPOgZCcQGegXb69W1f42GzrrYh53p7OjolNKP374c73cD_Rf4Zfi- |
| linkProvider | Springer Nature |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB7RrQRcKBQKgQIWQj1AXSWxk3iPVdWypQ_1sJUKFyt-oWiXBG12kcKvZ7xJuioUpOaSg-3YmYzHM5nPnwHeR1kuVOgiqoR2FFcoRkVkDWWxdolx3KduPNriPB1d8s9XyVW3j7vu0e59SnJpqVeb3eI48zACD0eMEtqswTrHEJwPYH3_05eTw94AszRZHnaKqzmj6K8P-2TmbQ-5sRytlTN3m6f5V5Z0ufgcbcC4H3aLOZnsLeZqT__6g9Hxju_1GB51zijZb7XnCdyz5SbcP-vS7Zuwc9ESWze7ZLzap1Xvkh1ysaK8bp7CVywmHeUDmk_SokRI5QhG8z89b_OsmpKqJKbwR1Y3UzQkKI_8O3ZDi9Kgfhky9RAR4jB-r-qiJkVJsF39DC6PDscHI9qd2kA1y7I5TYzhlg9Vbq1QmYkcz1Rqw1AneZzrPLNhok0cYinLMfhxKWqL1Rg22lSooUvYFgzKqrQvgCjt_7eIBFtbbgQXOV7acr10y4QIIOw_ntQdpbk_WWMqV2TMXrgShSu9cGUTwIfrJj9aPo__VX6HGiEnupCehdvfv1VyMpMYaxxj7MQEersBkF5hJE5Nn2_JS1stapkxNvSEjnEAz1tFuu4y9tRrLAsD-NgrheyMR_3v8by8U-238GA0PjuVp8fnJ6_gYQt78JCjbRjMZwv7Gr2puXrTzZ7faAIVqQ |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RrVRx4VFe4Wkh1APUbTbOw3usoEtLodpDKxUuJvGjinabVJssUvj1zGySroCChMglB9txPBnbM5nP3wC8GiapzHw35JnUjuMOJbgcWsNFoF1kXEihG0JbHMcHp-GHs-isy3Na9Wj3PiTZnmkglqai3r00bnd18C0IEoIUEDRxGPFmDdZD4mYfwPre-89H-_1iLOJomfgUd3bB0XYf9YHN6x7y09a0VszddVbnbxHT5UY0vg1f-yG0-JPpzqLOdvT3X9gd_2OMd-BWZ6SyvVar7sINW2zCxqcuDL8JW5OW8LrZZier81vVNttikxUVdnMPvmAx66ggcFllLXqElY6hl_-N-Jzn5YyVBTM5pbJuZrjAoGzSC-yG54VBvTNsRtAR5tCvL6u8YnnBsF11H07H-ydvD3iXzYFrkSQ1j4wJbTjKUmtllpihC5Mstr6vozRIdZpYP9Im8LFUpOgUuRi1yGp0J20ss5GLxAMYFGVhHwHLNP2HkRG2tqGRoUzx0jbUS3NNSg_8_kMq3VGdU8aNmVqRNJNwFQpXkXBV48HrqyaXLc_H3yq_RO1QU50rYuem-3mppnOFPsgh-lRCohXsAeuVR-GUpThMWthyUalEiBERPQYePGyV6qrLgCjZROJ78KZXENUtKtWf3-fxP9V-ARuTd2P18fD46AncbNEQhER6CoN6vrDP0Miqs-fdRPoBBggejQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+protective+effect+of+resveratrol+on+dimethylnitrosamine-induced+liver+fibrosis+in+rats&rft.jtitle=Archives+of+pharmacal+research&rft.au=Hong%2C+Sang-Won&rft.au=Jung%2C+Kyung+Hee&rft.au=Zheng%2C+Hong-Mei&rft.au=Lee%2C+Hee-Seung&rft.date=2010-04-01&rft.issn=1976-3786&rft.eissn=1976-3786&rft.volume=33&rft.issue=4&rft.spage=601&rft_id=info:doi/10.1007%2Fs12272-010-0415-y&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0253-6269&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0253-6269&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0253-6269&client=summon |